2095 - 2095 |
Pharmaceutical proteomics Anderson L, Witzmann F, Langen H, Steiner S |
2099 - 2104 |
Proteomics: Applications and opportunities in preclinical drug development Steiner S, Witzmann FA |
2105 - 2114 |
Mass spectrometry: A tool for the identification of proteins separated by gels Lahm HW, Langen H |
2115 - 2121 |
Bladder squamous cell carcinoma biomarkers derived from proteomics Celis JE, Wolf H, Ostergaard M |
2122 - 2128 |
Two-dimensional electrophoresis of liver proteins: Characterization of a drug-induced hepatomegaly in rats Newsholme SJ, Maleeff BF, Steiner S, Anderson NL, Schwartz LW |
2129 - 2137 |
Proteomics to display lovastatin-induced protein and pathway regulation in rat liver Steiner S, Gatlin CL, Lennon JJ, McGrath AM, Aponte AM, Makusky AJ, Rohrs MC, Anderson NL |
2138 - 2147 |
Toxicity of chemical mixtures: Proteomic analysis of persisting liver and kidney protein alterations induced by repeated exposure of rats to JP-8 jet fuel vapor Witzmann FA, Carpenter RL, Ritchie GD, Wilson CL, Nordholm AF, Rossi J |
2148 - 2161 |
Two-dimensional database of mouse liver proteins: Changes in hepatic protein levels following treatment with acetaminophen or its nontoxic regioisomer 3-acetamidophenol Fountoulakis M, Berndt P, Boelsterli UA, Crameri F, Winter M, Albertini S, Suter L |
2162 - 2169 |
Mouse liver selenium-binding protein decreased in abundance by peroxisome proliferators Giometti CS, Liang XL, Tollaksen SL, Wall DB, Lubman DM, Subbarao V, Rao MS |
2170 - 2179 |
Proteins of rat serum V: Adjuvant arthritis and its modulation by nonsteroidal anti-inflammatory drugs Eberini I, Agnello D, Miller I, Villa P, Fratelli M, Ghezzi P, Gemeiner M, Chan J, Aebersold R, Gianazza E |
2180 - 2195 |
A comprehensive characterization of the T-cell antigen receptor complex composition by microcapillary liquid chromatography-tandem mass spectrometry Heller M, Goodlett DR, Watts JD, Aebersold R |
2196 - 2208 |
A general method for the rapid characterization of tyrosine-phosphorylated proteins by mini two-dimensional gel electrophoresis Ducret A, Desponts C, Desmarais S, Gresser MJ, Ramachandran C |
2209 - 2218 |
Deamidation as a widespread phenomenon in two-dimensional polyacrylamide gel electrophoresis of human blood plasma proteins Sarioglu H, Lottspeich F, Walk T, Jung G, Eckerskorn C |
2219 - 2227 |
Tracking pathology with proteomics: Identification of in vivo degradation products of alpha B-crystallin Colvis CM, Duglas-Tabor Y, Werth KB, Vieira NE, Kowalak JA, Janjani A, Yergey AL, Garland DL |
2228 - 2234 |
Proteomic analysis of the atrophying rat soleus muscle following denervation Isfort RJ, Hinkle RT, Jones MB, Wang F, Greis KD, Sun YP, Keough TW, Anderson NL, Sheldon RJ |
2235 - 2242 |
Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines Ornstein DK, Gillespie JW, Paweletz CP, Duray PH, Herring J, Vocke CD, Topalian SL, Bostwick DG, Linehan WM, Petricoin EF, Emmert-Buck MR |
2243 - 2251 |
Automatic Poisson peak harvesting for high throughput protein identification Breen EJ, Hopwood FG, Williams KL, Wilkins MR |
2252 - 2265 |
Tandem mass spectrometry methods for definitive protein identification in proteomics research Keough T, Lacey MP, Fieno AM, Grant RA, Sun YP, Bauer MD, Begley KB |
2266 - 2283 |
Identification of two-dimensionally separated human cerebrospinal fluid proteins by N-terminal sequencing, matrix-assisted laser desorption/ionization-mass spectrometry, nanoliquid chromatography-electrospray ionization-time of flight-mass spectrometry, and tandem mass spectrometry Raymackers J, Daniels A, De Brabandere V, Missiaen C, Dauwe M, Verhaert P, Vanmechelen E, Meheus L |